Publiziert in: Marktpuls, Unternehmen
Frei

SHL’s Annual Report 2013 available now Dienstag, 25. März 2014 - 07:04

Press release

Press release (PDF)

SHL’s Annual Report 2013 available now

Tel Aviv/Zurich – March 25, 2014 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN / ADR program listed over-the counter; Symbol: SMDCY) announced today that its Annual Report 2013 is now available on www.shl-telemedicine.com. The Annual Report contains detailed information about SHL's financial performance, strategy, structure and corporate governance in 2013. It is available in English.

 

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information please visit our web site at www.shl-telemedicine.com.

 

Contacts:

Erez Alroy

Co-CEO

P:+972 3 5612212,

ereza@shl-telemedicine.com

 

Martin Meier-Pfister

IRF Communications

P: +41 43 244 81 40

shl@irfcom.ch

 

Garth Russell / Elizabeth Barker

KCSA Strategic Communications

P: 212-896-1250 / 212-896-1203

grussell@kcsa.com/ ebarker@kcsa.com

 

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements